Use of Most Contraceptive Methods Declined from 2019 to 2022, Except Vasectomies, According to New Data
More advanced practice clinicians and fewer physicians are providing contraception services, researchers reported.
Nirsevimab for RSV Reduces Infant Hospitalizations by 82% in Real-World Study
In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).
Anxiety Linked to Increased Risk for Acute Exacerbations in Older Adults with COPD
Nearly 20% of an older cohort with COPD reported anxiety that was subsequently associated with more severe symptoms and acute exacerbations.
Atrial Fibrillation May be More Common in Younger Adults than Previously Thought: Daily Dose
Your daily dose of the clinical news you may have missed.
Treatment by Female Clinicians Associated with Lower Mortality, Hospital Readmissions: Daily Dose
Mental Health Risks Persist for Years Following Severe Maternal Morbidity in Pregnancy
Severe maternal morbidity during pregnancy increases the risk for mental health hospitalization or ED visits for as long as 13 years, a Canadian study found.
The 10 States with the Largest ↑ Increase in Diabetes Dx & 5 States with the Largest ↓ Decrease
Diagnoses of diabetes increased the most in South Dakota between 2018 and 2021 at 18.45%; diagnoses decreased the most in Hawaii at 15.61%. More, here.
Final USPSTF Recommendation on Breast Cancer Screening Lowers Starting Age from 50 to 40 Years, Highlights Racial Disparities
The USPSTF decision to reduce age of initiation is based on increasing rates of breast cancer in younger women; the group vows more research on higher mortality for Black women.
Cardiovascular-Kidney-Metabolic (CKM) Syndrome Affects Nearly All US Adults
The majority of the US adult population meets criteria for subclinical CKM syndrome indicating "an urgent need for population-wide risk reduction measures."
COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone: Daily Dose
The Pipeline for New MASLD & MASH Treatments is Promising, says Naim Alkhouri, MD
Following the landmark FDA approval of resmetirom for MASH with fibrosis, hepatologist and researcher Alkhouri describes more mid- and late-stage candidates.
Dermavant: FDA Accepts sNDA for Tapinarof Cream 1% for Treatment of Adults, Children with Atopic Dermatitis
The FDA PDUFA date for taparinof cream 1% will be during the 4th quarter, Dermavant said, with approval based on ADORING phase 3 clinical trial data.
A MASLD Mantra to Practice By: Screen, Stage, Treat
Hepatologist Naim Alkhouri, MD, offered 3 take-home thoughts for primary care colleagues to help increase early detection of MASLD.
Merck's 21-Valent Pneumococcal Vaccine Delivers More Positive Phase 3 Data in Advance of 6-17-2024 PDUFA Date
In STRIDE 10, V116 was superior to PPSV23 in adults aged ≥50 years and naive to pneumococcal vaccine for 8 of 9 serotypes unique to Merck's investigational shot.
The FDA Approval of Resmetirom for MASH Changes Everything—for Patients and their Physicians
Naim Alkhouri, MD, a transplant hepatologist and a resmetirom investigator, talks here about the life-changing impact the drug will have for all touched by MASH.
Early Detection of MASLD in Primary Care: The Essentials with Naim Alkhouri, MD
Primary care is where early detection and treatment of liver disease should begin and as Dr Alkhouri highlights here, all the right tools are already at hand.
American Liver Foundation Announces First Federally-Funded Research on MASLD
The national study on the true prevalence of metabolic dysfunction-associated liver disease is essential to screening, prevention, and treatment efforts, says AFL CEO Stiehl.
Adults with Obesity Who Receive Semaglutide as First Weight Loss Medication Lose More Weight
Adults receiving semaglutide for the first time achieved weight loss of 14.3% at 12 months vs 10.6% among those who had previously taken a different antiobesity drug.
Shingrix Effective Against Shingles for up to 11 Years Post-Vaccination: Daily Dose
FDA Approves First New Antibiotic in Decades for Uncomplicated UTI
Pivmecillinam is an aminopenicillin, a class of beta-lactam antibiotics with a mechanism of action that may help reduce rising levels of antibiotic resistance.
